The role of sex and gender in the selection of Alzheimer patients for clinical trial prescreening
Saved in:
Rosende-Roca, M., et al., The role of sex and gender in the selection of Alzheimer patients for clinical trial prescreening. Alzheimer's Research & Therapy, vol. 13, 2021, p. 1-13.
Ref.
573260
Location:
SIIS Archivo
Palabras clave:
Enfermedades mentales, Demencia, Enfermedad de Alzheimer, Igualdad de género, Mujer, Hombre, Deterioro cognitivo, Factor de riesgo, Efectos, Europa
Enfermedades mentales, Demencia, Enfermedad de Alzheimer, Igualdad de género, Mujer, Hombre, Deterioro cognitivo, Factor de riesgo, Efectos, Europa
Similar Items: The role of sex and gender in the selection of Alzheimer patients for clinical trial prescreening
- World Alzheimer Report 2026. A new era in dementia clinical trials
- ¿TENGO O NO TENGO ALZHEIMER?
- Analysis of risk-factors associated with hospital-acquired pneumonia in patients with alzheimer’s disease based on gender differences
- EL DETERIORO COGNITIVO EN LA ENFERMEDAD DE ALZHEIMER
- RATE OF COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER'S DISEASE: THE ROLE OF COMORBIDITY
- PROGRESSION OF COGNITIVE IMPAIRMENT IN ALZHEIMER'S DISEASE